Clinical Trial Update: BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BPM31510 in combination with gemcitabine for advanced pancreatic cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BPM31510 (BPM31510)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: BPGbio | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-03-26